ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Antibodies to Vascular Autoantigens Are Associated with Poor Long-Term Survival of Liver Re-Transplant

Q. Xu1, V. C. McAlister2, S. Leckie2, A. A. House2, A. Zeevi1

1Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada

Meeting: 2020 American Transplant Congress

Abstract number: 372

Keywords: Antibodies, Autoimmunity, Graft survival, Liver transplantation

Session Information

Date: Saturday, May 30, 2020

Session Name: Liver Retransplantation and Other Complications

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:51pm-4:03pm

Location: Virtual

Related Abstracts
  • MELD Score and Anti-Angiotensin Receptor Antibody Predict Long-Term Survival of Liver Re-Transplant
  • Limited Impact of Pre-Existing Donor Specific HLA Antibodies on Long Term Survival After First Adult Liver Transplantation.

*Purpose: Autoantibodies, which may be generated in transplantation through the exposure of cryptic antigens, are reported to be detrimental for allograft survival. We have demonstrated that pre-formed Angiotensin II Type I Receptor agonistic autoantibodies (AT1R-AA) are associated with poor allograft survival in liver retransplantation. Here we examine the effect of other pre-formed autoantibodies on graft survival after liver retransplantation.

*Methods: We studied a single-center retrospective cohort of 93 patients (1991-2018) who received second liver transplant. Pre-retransplant sera were tested with Luminex-based solid-phase assays for antibodies to 33 autoantigens. The primary outcome is survival of the second liver graft.

*Results: With follow-up for up to 25 years, 48/93 (51.6%) patients had lost second liver transplants. Seven autoantibodies were found to be significantly higher (p<0.05) in patients who lost grafts vs. whose grafts were still functioning. In univariate Cox regression, autoantibodies to LG3, a C-terminal fragment of Perlecan [HR=2.472 (1.376-4.44), p=0.002], Agrin [HR=1.83 (1.023-3.271), p=0.042], and Chromatin assembly factor 1 subunit B [HR=2.356 (1.053-5.275), p=0.037] were found to be associated with poor graft survival. In the multivariate model adjusting age and gender, LG3 autoantibody [HR=2.345 (1.105-4.980), p=0.027] and AT1R-AA [2.091 (1.066- 4.098), p=0.032] were significant and independent contributors for graft loss. 22/93 patients (23.4%) had positive autoantibodies to LG3, of which 18 (81.8%) had lost their grafts. In Kaplan-Meier analysis (Figure 1), patients with positive autoantibodies to LG3 had significantly worse graft survival (p=0.002) than those with negative LG3 autoantibodies.

*Conclusions: Autoantibodies to either LG3 or AT1R were found to be associated with inferior long-term outcomes of a second liver transplant. AT1R-AA causes vasoconstriction. Autoantibodies to LG3 are not yet defined as agonistic or antagonistic but have been shown to aggravate the ischemia-reperfusion injury and vascular rejection in kidney transplants. The detrimental effect of autoantibodies after transplantation may be mediated through their effect on graft and host vasculature.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Xu Q, McAlister VC, Leckie S, House AA, Zeevi A. Antibodies to Vascular Autoantigens Are Associated with Poor Long-Term Survival of Liver Re-Transplant [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/antibodies-to-vascular-autoantigens-are-associated-with-poor-long-term-survival-of-liver-re-transplant/. Accessed March 8, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.